eujobs.coEU jobs in brussels
Post a JobHeadhunter

European Society for Organ Transplantation

Acronym: ESOT

General Information

Identification Code: 344914634803-90
Website: [object Object]
Entity Form: Foundation
Registration Category: Trade unions and professional associations
Registration Date: 5/12/2019
Last Update: 11/22/2023
EP Accredited Number: 0

Mission & Interests

Goals: ESOT provides the environment, knowledge and resources to encourage professional development of researchers and healthcare professionals in the field of organ transplantation, replacement and regeneration.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
  • Education and training
  • International co-operation and development
  • Public health
  • Research and innovation
Levels of Interest:
  • sub-national
  • european
  • global

Activities

Main EU Legislative Proposals: Improving Integrated people-centered Health Care Solutions (INCASO) Improving Organ Donation and Transplantation in the EU
Communication Activities: Development of ESOT Manifesto 2023-25 Participation to Gasstein Heallth Forum 2022 Participatin to Santander Summit 2023
Inter-institutional or Unofficial Groupings: Climate change, biodiversity and sustainable development,Anti-racism and diversity,Cancer

Head Office

Address: Westerdoksdijk 423
Post Code: 1013 BX
City: Amsterdam
Country: NETHERLANDS
Phone: [object Object]

EU Office

Address: Westerdoksdijk 423
Post Code: 1013 BX
City: Amsterdam
Country: NETHERLANDS
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: EU4Health – Building Resilience Against crisis: a systematic and global approach to adVancE organ Safety and supply in Transplantation ESOT coordinates BRAVEST, a European Funding Research Project under the EU4 Health programme. The project aims to analyse the factors that have influenced the organ procurement processes before, during and after the onset of the SARS-CoV2 pandemic, as a paradigm of the resilience of the donor procurement network in ensuring safety and continuity of supply of organ donation. https://www.bravest-project.eu/ HORUS - ORUS involves the first longitudinal cohort of European SOT recipients. In a sub-‘HORUS-exploratory cohort’, we will perform a thorough investigation of viral, clinical and immunological characteristics. Combining those parameters will provide a signature early after transplantation to predict the risk of developing CMV infection and a signature at Day 0 of infection to predict the risk of CMV disease severity. This signature will then be validated retrospectively by the whole cohort and prospectively in a ‘proof-of-concept’ study. Moreover, HORUS will include functional in vitro and mouse models to investigate the mechanisms of lymphocyte response to CMV and provide innovative methods to increase CMV-specific immunity. Altogether, HORUS will enhance personalised clinical prevention and the treatment of CMV disease, ultimately improving patient outcomes. https://www.horus-project.eu/project

Membership Information

Members10 Percent: 1
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 2
Members F T E: 0.3499999940395355

Structure

Structure Type: Structure
Is Member Of: EU Health Coalition
Organisation Members: European Public Health Alliance (EPHA)